Literature DB >> 28057817

Contractile efficiency of dystrophic mdx mouse muscle: in vivo and ex vivo assessment of adaptation to exercise of functional end points.

Roberta Francesca Capogrosso1,2, Paola Mantuano1, Anna Cozzoli1, Francesca Sanarica1, Ada Maria Massari1, Elena Conte1, Adriano Fonzino1, Arcangela Giustino3, Jean-Francois Rolland1, Angelo Quaranta4, Michela De Bellis1, Giulia Maria Camerino1, Robert W Grange5, Annamaria De Luca6.   

Abstract

Progressive weakness is a typical feature of Duchenne muscular dystrophy (DMD) patients and is exacerbated in the benign mdx mouse model by in vivo treadmill exercise. We hypothesized a different threshold for functional adaptation of mdx muscles in response to the duration of the exercise protocol. In vivo weakness was confirmed by grip strength after 4, 8, and 12 wk of exercise in mdx mice. Torque measurements revealed that exercise-related weakness in mdx mice correlated with the duration of the protocol, while wild-type (WT) mice were stronger. Twitch and tetanic forces of isolated diaphragm and extensor digitorum longus (EDL) muscles were lower in mdx compared with WT mice. In mdx, both muscle types exhibited greater weakness after a single exercise bout, but only in EDL after a long exercise protocol. As opposite to WT muscles, mdx EDL ones did not show any exercise-induced adaptations against eccentric contraction force drop. qRT-PCR analysis confirmed the maladaptation of genes involved in metabolic and structural remodeling, while damage-related genes remained significantly upregulated and angiogenesis impaired. Phosphorylated AMP kinase level increased only in exercised WT muscle. The severe histopathology and the high levels of muscular TGF-β1 and of plasma matrix metalloproteinase-9 confirmed the persistence of muscle damage in mdx mice. Therefore, dystrophic muscles showed a partial degree of functional adaptation to chronic exercise, although not sufficient to overcome weakness nor signs of damage. The improved understanding of the complex mechanisms underlying maladaptation of dystrophic muscle paves the way to a better managment of DMD patients.NEW & NOTEWORTHY We focused on the adaptation/maladaptation of dystrophic mdx mouse muscles to a standard protocol of exercise to provide guidance in the development of more effective drug and physical therapies in Duchenne muscular dystrophy. The mdx muscles showed a modest functional adaptation to chronic exercise, but it was not sufficient to overcome the progressive in vivo weakness, nor to counter signs of muscle damage. Therefore, a complex involvement of multiple systems underlies the maladaptive response of dystrophic muscle.
Copyright © 2017 the American Physiological Society.

Entities:  

Keywords:  Duchenne muscular dystrophy; in vivo and ex vivo weakness; isometric and eccentric contraction; mdx mouse model; treadmill exercise

Mesh:

Substances:

Year:  2017        PMID: 28057817     DOI: 10.1152/japplphysiol.00776.2015

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  18 in total

1.  Inspiratory pressure-generating capacity is preserved during ventilatory and non-ventilatory behaviours in young dystrophic mdx mice despite profound diaphragm muscle weakness.

Authors:  David P Burns; Kevin H Murphy; Eric F Lucking; Ken D O'Halloran
Journal:  J Physiol       Date:  2019-01-13       Impact factor: 5.182

2.  Progressing the field of Regenerative Rehabilitation through novel interdisciplinary interaction.

Authors:  Victor Cheuy; Silvia Picciolini; Marzia Bedoni
Journal:  NPJ Regen Med       Date:  2020-09-23

3.  Mineralocorticoid receptor antagonists improve membrane integrity independent of muscle force in muscular dystrophy.

Authors:  J Spencer Hauck; Jeovanna Lowe; Neha Rastogi; Kevin E McElhanon; Jennifer M Petrosino; Kyra K Peczkowski; Ashlee N Chadwick; Jonathan G Zins; Federica Accornero; Paul M L Janssen; Noah L Weisleder; Jill A Rafael-Fortney
Journal:  Hum Mol Genet       Date:  2019-06-15       Impact factor: 6.150

4.  Distinct roles of the dystrophin-glycoprotein complex: α-dystrobrevin and α-syntrophin in the maintenance of the postsynaptic apparatus of the neuromuscular synapse.

Authors:  Isabel Martinez-Pena Y Valenzuela; Po-Ju Chen; Joseph Barden; Olivia Kosloski; Mohammed Akaaboune
Journal:  Hum Mol Genet       Date:  2022-07-21       Impact factor: 5.121

5.  A novel murine muscle loading model to investigate Achilles musculotendinous adaptation.

Authors:  Sabah N Rezvani; Anne E C Nichols; Robert W Grange; Linda A Dahlgren; P Gunnar Brolinson; Vincent M Wang
Journal:  J Appl Physiol (1985)       Date:  2021-02-11

6.  Low-intensity training provokes adaptive extracellular matrix turnover of a muscular dystrophy model.

Authors:  Thaís P Gaiad; Murilo X Oliveira; Adalfredo R Lobo; Lívia R Libório; Priscilla A F Pinto; Danielle C Fernandes; Ana Paula Santos; Carlos Eduardo Ambrósio; Alex Sander D Machado
Journal:  J Exerc Rehabil       Date:  2017-12-27

7.  Ryanodine channel complex stabilizer compound S48168/ARM210 as a disease modifier in dystrophin-deficient mdx mice: proof-of-concept study and independent validation of efficacy.

Authors:  Roberta Francesca Capogrosso; Paola Mantuano; Kitipong Uaesoontrachoon; Anna Cozzoli; Arcangela Giustino; Todd Dow; Sadish Srinivassane; Marina Filipovic; Christina Bell; Jack Vandermeulen; Ada Maria Massari; Michela De Bellis; Elena Conte; Sabata Pierno; Giulia Maria Camerino; Antonella Liantonio; Kanneboyina Nagaraju; Annamaria De Luca
Journal:  FASEB J       Date:  2018-01-03       Impact factor: 5.834

8.  Calpain 3 and CaMKIIβ signaling are required to induce HSP70 necessary for adaptive muscle growth after atrophy.

Authors:  Irina Kramerova; Jorge A Torres; Ascia Eskin; Stanley F Nelson; Melissa J Spencer
Journal:  Hum Mol Genet       Date:  2018-05-01       Impact factor: 6.150

9.  Dual Action of Mexiletine and Its Pyrroline Derivatives as Skeletal Muscle Sodium Channel Blockers and Anti-oxidant Compounds: Toward Novel Therapeutic Potential.

Authors:  Michela De Bellis; Francesca Sanarica; Alessia Carocci; Giovanni Lentini; Sabata Pierno; Jean-François Rolland; Diana Conte Camerino; Annamaria De Luca
Journal:  Front Pharmacol       Date:  2018-01-12       Impact factor: 5.810

10.  Ergogenic Effect of BCAAs and L-Alanine Supplementation: Proof-of-Concept Study in a Murine Model of Physiological Exercise.

Authors:  Paola Mantuano; Gianluca Bianchini; Ornella Cappellari; Brigida Boccanegra; Elena Conte; Francesca Sanarica; Antonietta Mele; Giulia M Camerino; Laura Brandolini; Marcello Allegretti; Michela De Bellis; Andrea Aramini; Annamaria De Luca
Journal:  Nutrients       Date:  2020-07-30       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.